Bexarotene
Active substance: bexarotene
CAPSULE, LIQUID FILLED · BEXAROTENE 75 mg/1
United StatesActive
Marketing holder: ANI Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BEXAROTENE · 75 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3fc7-721e-8871-21aafe6d22ec,01a1208d-05c6-7720-8059-b60a0462cee0,01a1208d-1fc1-7b1a-acda-b023b1f4fd45,01a12092-c6c0-77ab-af90-19cdd561d25d,01a12097-10b2-7798-8d83-756f64ba0ff9;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 43975-315
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 43975-315 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43975-315 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43975-315 · Verified 2026-10-09 · open in source